Scholarly Index
Helen Swaisland
AstraZeneca (United Kingdom); 7,890 total citations; 50 total publications; best world rank #806
AstraZeneca (United Kingdom)
7,890Total citations
50Total publications
27H-index
Published ranking records
| Field | Window | World rank | National rank | Impact score |
|---|---|---|---|---|
| PARP inhibition in cancer therapy | Lifetime | 806 | GB 70 | 92.06 |